Search hospitals > Oregon > Portland
Kaiser Permanente Northwest
Claim this profilePortland, Oregon 97227
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
135 reported clinical trials
3 medical researchers
Summary
Kaiser Permanente Northwest is a medical facility located in Portland, Oregon. This center is recognized for care of Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Breast cancer and other specialties. Kaiser Permanente Northwest is involved with conducting 135 clinical trials across 322 conditions. There are 3 research doctors associated with this hospital, such as Abdul Hai Mansoor, Sandeep Mashru, and Gloria Coronado.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Abdul Hai MansoorKaiser Permanente Northwest1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
23 reported clinical trials
67 drugs studied
Sandeep MashruKaiser Permanente Northwest3 years of reported clinical research
Studies Skin Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
34 drugs studied
Gloria CoronadoKaiser Permanente Northwest3 years of reported clinical research
Studies Uterine Tumors
Studies Blood Cancers
1 reported clinical trial
1 drug studied
Clinical Trials running at Kaiser Permanente Northwest
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Breast cancer
Multiple Myeloma
Pancreatic Cancer
Skin Cancer
Prostate Cancer
Follicular Lymphoma
Kidney Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente Northwest?
Kaiser Permanente Northwest is a medical facility located in Portland, Oregon. This center is recognized for care of Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Breast cancer and other specialties. Kaiser Permanente Northwest is involved with conducting 135 clinical trials across 322 conditions. There are 3 research doctors associated with this hospital, such as Abdul Hai Mansoor, Sandeep Mashru, and Gloria Coronado.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.